_Īssociated Press writers Marion Renault, Andrew Welsh-Huggins, Rebecca Santana, Dylan Lovan, Tamara Lush, Jeff Turner and Kathy Young contributed to this report. The FDA instructed providers not to give the vaccine to those with a known history of severe allergic reactions to any of its ingredients. But the American College of Obstetricians and Gynecologists said Sunday that vaccination should not be withheld from pregnant women who otherwise would qualify.Īlso, regulators in Britain are investigating a few severe allergic reactions. The shots still must be studied in children and during pregnancy. That research is continuing to try to answer additional questions.įor example, while the vaccine is effective at preventing COVID-19 illness, it is not clear if it will stop the symptomless spread that accounts for half of all cases. Still, the vaccine was cleared for emergency use before a final study in nearly 44,000 people was complete. “As soon as you can get it, please do so.” Katherine Baumgarten, who got her shot on Day 1. “We know it works well,” said Ochsner infectious-disease expert Dr. The FDA, considered the world’s strictest medical regulator, said the Pfizer-BioNTech vaccine, which was developed at breakneck speed less than a year after the virus was identified, appears safe and strongly protective, and the agency laid out the data in a daylong public meeting last week for scientists and consumers alike to see. “I know it’s going to be a big hurdle to convince people because it’s new, it’s uncertain,” said intensive care nurse Helen Cordova, who received a vaccination card after getting a shot at Kaiser Permanente Los Angeles Medical Center. Just half of Americans say they want to get vaccinated, while about a quarter don’t and the rest are unsure, according to a recent poll by The Associated Press-NORC Center for Public Health Research.
Plus, the shots can cause temporary fever, fatigue and aches as they rev up people’s immune systems, forcing hospitals to stagger employee vaccinations. “We’re also in the middle of a surge, and it’s the holidays, and our health care workers have been working at an extraordinary pace,” said Sue Mashni, chief pharmacy officer at Mount Sinai Health System in New York City. hopes for enough of both vaccines together to vaccinate 20 million people by the end of the month, and 30 million more in January, there won’t be enough for the average person to get a shot until spring.įor now the hurdle is to rapidly get vaccine into the arms of millions, not just doctors and nurses but other at-risk health workers such as janitors and food handlers - and then deliver a second dose three weeks later. And later this week, the FDA will decide whether to greenlight the world’s second rigorously studied COVID-19 vaccine, made by Moderna Inc. More of the Pfizer-BioNTech vaccine will arrive each week. The nearly 3 million doses now being shipped are just a down payment on the amount needed. Seoane, who is Cuban American, urged “all of my Hispanic brothers and sisters to do it. Leonardo Seoane, chief academic officer at Ochsner Health in suburban New Orleans, after getting his dose. Getting vaccinated is “a privilege,” said Dr. Health experts know a wary public is watching the vaccination campaign, especially communities of color that have been hit hard by the pandemic but, because of the nation’s legacy of racial health disparities and research abuses against Black people, have doubts about the vaccine. It just represents a moral failing,” said Jennifer Nuzzo, a public health researcher at Johns Hopkins. “To think, now we can just absorb in our country 3,000 deaths a day as though it were just business as usual. It is equal to a 9/11 attack every day for more than 100 days.
It is more than five times the number of Americans killed in the Vietnam War. The number of dead rivals the population of St. The campaign began the same day the U.S death toll from the surging outbreak crossed the 300,000 threshold, according to the count kept by Johns Hopkins University. Nursing home residents also get priority, and a Veterans Affairs Medical Center in Bedford, Massachusetts, announced via Twitter that its first dose went to a 96-year-old World War II veteran, Margaret Klessens. “This is 20,000 doses of hope,” John Couris, president and chief executive of Tampa General Hospital said of the first delivery.
0 kommentar(er)
